U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 2 of 2 results

DICLAZURIL

MORE DETAILS

  K110K1B1VE

Status:
Possibly Marketed Outside US
First approved in 2001
Class (Stereo):
CHEMICAL (RACEMIC)
Targets:
Differentiation during parasite development
2
Merozoite production
2
Conditions:
Coccidiosis
45
Equine protozoal myeloencephalitis
3
Diclazuril is a main component of veterinary drugs used for the treatment of coccidiosis (chickens, turkeys, rabbits, etc) and equine protozoal myeloencephalitis (horses). When used for the treatment of coccidiosis, it acts by causing the degeneratio...

DICLAZURIL SODIUM

MORE DETAILS

  5K4327702E

Status:
Possibly Marketed Outside US
First approved in 2001
Class (Stereo):
CHEMICAL (RACEMIC)
Targets:
Differentiation during parasite development
2
Merozoite production
2
Conditions:
Coccidiosis
45
Equine protozoal myeloencephalitis
3
Diclazuril is a main component of veterinary drugs used for the treatment of coccidiosis (chickens, turkeys, rabbits, etc) and equine protozoal myeloencephalitis (horses). When used for the treatment of coccidiosis, it acts by causing the degeneratio...
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966